TCL Archive NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive May 10, 1996
TCL Archive In Brief: Indiana U. Planning “World Class” Cancer Center; UCLA Names Two New Cancer Control Directors June 6, 1986
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
